233 related articles for article (PubMed ID: 3276362)
1. The correlation of breakpoint cluster region rearrangement and p210 phl/abl expression with morphological analysis of Ph-negative chronic myeloid leukemia and other myeloproliferative diseases.
Wiedemann LM; Karhi KK; Shivji MK; Rayter SI; Pegram SM; Dowden G; Bevan D; Will A; Galton DA; Chan LC
Blood; 1988 Feb; 71(2):349-55. PubMed ID: 3276362
[TBL] [Abstract][Full Text] [Related]
2. Philadelphia chromosome-positive chronic myelogenous leukemia with deleted fusion of BCR and ABL genes.
Ohyashiki K; Ohyashiki JH; Iwabuchi H; Tauchi T; Iwabuchi A; Toyama K
Jpn J Cancer Res; 1990 Jan; 81(1):35-42. PubMed ID: 2157692
[TBL] [Abstract][Full Text] [Related]
3. [Molecular genetics of the pathogenesis and classification of chronic myelocytic leukemia].
Bartram CR
Onkologie; 1987 Jun; 10(3):127-32. PubMed ID: 3306531
[TBL] [Abstract][Full Text] [Related]
4. Review of clinical, cytogenetic, and molecular aspects of Ph-negative CML.
van der Plas DC; Grosveld G; Hagemeijer A
Cancer Genet Cytogenet; 1991 Apr; 52(2):143-56. PubMed ID: 2021916
[TBL] [Abstract][Full Text] [Related]
5. Rearrangement of the breakpoint cluster region and expression of P210 BCR-ABL in a "masked" Philadelphia chromosome-positive acute myeloid leukemia.
Price CM; Rassool F; Shivji MK; Gow J; Tew CJ; Haworth C; Goldman JM; Wiedemann LM
Blood; 1988 Nov; 72(5):1829-32. PubMed ID: 3179449
[TBL] [Abstract][Full Text] [Related]
6. Molecular cytogenetic characterization of Philadelphia-negative rearrangements in chronic myeloid leukemia patients.
Bennour A; Bellâaj H; Ben Youssef Y; Elloumi M; Khelif A; Saad A; Sennana H
J Cancer Res Clin Oncol; 2011 Sep; 137(9):1329-36. PubMed ID: 21739181
[TBL] [Abstract][Full Text] [Related]
7. Chromosome 22 breakpoints in variant Philadelphia translocations and Philadelphia-negative chronic myeloid leukemia.
Browett PJ; Cooke HM; Secker-Walker LM; Norton JD
Cancer Genet Cytogenet; 1989 Feb; 37(2):169-77. PubMed ID: 2649233
[TBL] [Abstract][Full Text] [Related]
8. Philadelphia chromosome-negative chronic myelogenous leukemia without breakpoint cluster region rearrangement: a chronic myeloid leukemia with a distinct clinical course.
Kurzrock R; Kantarjian HM; Shtalrid M; Gutterman JU; Talpaz M
Blood; 1990 Jan; 75(2):445-52. PubMed ID: 2403827
[TBL] [Abstract][Full Text] [Related]
9. Oncogene activation by chromosomal rearrangement in chronic myelocytic leukemia.
De Klein A
Mutat Res; 1987 Sep; 186(2):161-72. PubMed ID: 3306360
[TBL] [Abstract][Full Text] [Related]
10. The chronic myelogenous leukemia-specific P210 protein is the product of the bcr/abl hybrid gene.
Ben-Neriah Y; Daley GQ; Mes-Masson AM; Witte ON; Baltimore D
Science; 1986 Jul; 233(4760):212-4. PubMed ID: 3460176
[TBL] [Abstract][Full Text] [Related]
11. Significance and correlations of molecular analysis results in patients with Philadelphia chromosome-negative chronic myelogenous leukemia and chronic myelomonocytic leukemia.
Kantarjian HM; Shtalrid M; Kurzrock R; Blick M; Dalton WT; LeMaistre A; Stass SA; McCredie KB; Gutterman J; Freireich EJ
Am J Med; 1988 Nov; 85(5):639-44. PubMed ID: 3189367
[TBL] [Abstract][Full Text] [Related]
12. Unique forms of the abl tyrosine kinase distinguish Ph1-positive CML from Ph1-positive ALL.
Clark SS; McLaughlin J; Crist WM; Champlin R; Witte ON
Science; 1987 Jan; 235(4784):85-8. PubMed ID: 3541203
[TBL] [Abstract][Full Text] [Related]
13. Leukemia cell lines: in vitro models for the study of Philadelphia chromosome-positive leukemia.
Drexler HG; MacLeod RA; Uphoff CC
Leuk Res; 1999 Mar; 23(3):207-15. PubMed ID: 10071072
[TBL] [Abstract][Full Text] [Related]
14. Fine mapping of chromosome 22 breakpoints within the breakpoint cluster region (bcr) implies a role for bcr exon 3 in determining disease duration in chronic myeloid leukemia.
Grossman A; Silver RT; Arlin Z; Coleman M; Camposano E; Gascon P; Benn PA
Am J Hum Genet; 1989 Nov; 45(5):729-38. PubMed ID: 2683759
[TBL] [Abstract][Full Text] [Related]
15. The BCR/ABL hybrid gene.
Groffen J; Heisterkamp N
Baillieres Clin Haematol; 1987 Dec; 1(4):983-99. PubMed ID: 3332859
[TBL] [Abstract][Full Text] [Related]
16. Rearrangement in the breakpoint cluster region and the clinical course in Philadelphia-negative chronic myelogenous leukemia.
Kurzrock R; Blick MB; Talpaz M; Velasquez WS; Trujillo JM; Kouttab NM; Kloetzer WS; Arlinghaus RB; Gutterman JU
Ann Intern Med; 1986 Nov; 105(5):673-9. PubMed ID: 3094418
[TBL] [Abstract][Full Text] [Related]
17. Molecular characterization of a variant Ph1 translocation t(9;22;11) (q34;q11;q13) in chronic myelogenous leukemia (CML) reveals the translocation of the 3'-part of BCR gene to the chromosome band 11q13.
Koduru PR; Goh JC; Pergolizzi RG; Lichtman SM; Broome JD
Oncogene; 1993 Dec; 8(12):3239-47. PubMed ID: 8247527
[TBL] [Abstract][Full Text] [Related]
18. Duplication of small segments within the major breakpoint cluster region in chronic myelogenous leukemia.
Litz CE; McClure JS; Copenhaver CM; Brunning RD
Blood; 1993 Mar; 81(6):1567-72. PubMed ID: 8453102
[TBL] [Abstract][Full Text] [Related]
19. Molecular biology of the Philadelphia positive leukaemias.
Morgan GJ; Wiedemann LM
Recenti Prog Med; 1989 Oct; 80(10):508-19. PubMed ID: 2690217
[TBL] [Abstract][Full Text] [Related]
20. Chromosome abnormalities in CML.
Hagemeijer A
Baillieres Clin Haematol; 1987 Dec; 1(4):963-81. PubMed ID: 3332858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]